81 related articles for article (PubMed ID: 24810927)
1. Overexpression of ANXA1 confers independent negative prognostic impact in rectal cancers receiving concurrent chemoradiotherapy.
Sheu MJ; Li CF; Lin CY; Lee SW; Lin LC; Chen TJ; Ma LJ
Tumour Biol; 2014 Aug; 35(8):7755-63. PubMed ID: 24810927
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Transcobalamin 1 is an Independent Negative Prognosticator in Rectal Cancers Receiving Concurrent Chemoradiotherapy.
Lee YY; Wei YC; Tian YF; Sun DP; Sheu MJ; Yang CC; Lin LC; Lin CY; Hsing CH; Li WS; Li CF; Hsieh PL; Lin CY
J Cancer; 2017; 8(8):1330-1337. PubMed ID: 28638446
[No Abstract] [Full Text] [Related]
3. REG3A overexpression functions as a negative predictive and prognostic biomarker in rectal cancer patients receiving CCRT.
Li WS; Chen TJ; Lee SW; Yang CC; Tian YF; Kuo YH; Tsai HH; Wu LC; Yeh CF; Shiue YL; Chou CL; Lai HY
Histol Histopathol; 2024 Jan; 39(1):91-104. PubMed ID: 37042618
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of FCGBP expression for treatment response and survival in rectal cancer patients undergoing chemoradiotherapy.
Su YT; Chen CH; Kang JW; Kuo HY; Yang CC; Tian YF; Yeh CF; Chou CL; Chen SH
Aging (Albany NY); 2024 May; 16(9):7889-7901. PubMed ID: 38709264
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of the Interaction between CEA and Hemoglobin in Neoadjuvant CCRT Outcomes in Rectal Cancer Patients.
Lai YH; Chang YT; Chang YJ; Tsai JT; Li MH; Lin JC
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137759
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis.
Sobral-Leite M; Wesseling J; Smit VT; Nevanlinna H; van Miltenburg MH; Sanders J; Hofland I; Blows FM; Coulson P; Patrycja G; Schellens JH; Fagerholm R; Heikkilä P; Aittomäki K; Blomqvist C; Provenzano E; Ali HR; Figueroa J; Sherman M; Lissowska J; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Phillips KA; ; Couch FJ; Olson JE; Vachon C; Visscher D; Brenner H; Butterbach K; Arndt V; Holleczek B; Hooning MJ; Hollestelle A; Martens JW; van Deurzen CH; van de Water B; Broeks A; Chang-Claude J; Chenevix-Trench G; Easton DF; Pharoah PD; García-Closas M; de Graauw M; Schmidt MK
BMC Med; 2015 Jul; 13():156. PubMed ID: 26137966
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.
Chiang SF; Huang KC; Chen WT; Chen TW; Ke TW; Chao KSC
Cancer Immunol Immunother; 2021 Oct; 70(10):2937-2950. PubMed ID: 33713152
[TBL] [Abstract][Full Text] [Related]
8. Planned Short-Course Radiation (scRT) is Superior to Upfront Concurrent Chemoradiation (CCRT) in Treating Metastatic Rectal Cancer.
Teng HW; Lin JK; Lin TC; Chen WS; Jiang JK; Yang SH; Wang HS; Chang SC; Lan YT; Lin CC; Lin HH; Huang SC
J Gastrointest Surg; 2020 May; 24(5):1092-1100. PubMed ID: 31140063
[TBL] [Abstract][Full Text] [Related]
9. The clinical significance of simple endoscopic scoring of patients with rectal cancer after concurrent chemoradiotherapy.
Choi JH; Kim JH; Lee DH; Byun S; Jung K; Kim SE; Moon W; Park MI; Park SJ
J Gastrointest Oncol; 2019 Dec; 10(6):1073-1079. PubMed ID: 31949924
[TBL] [Abstract][Full Text] [Related]
10. p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients.
Ooi LC; Ho V; Zhu JZ; Lim S; Chung L; Abubakar A; Rutland T; Chua W; Ng W; Lee M; Morgan M; MacKenzie S; Lee CS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255799
[TBL] [Abstract][Full Text] [Related]
11. The Association of the Epidermal Growth Factor Receptor (EGFR) Immunoexpression With Prognostic Parameters in Adenocarcinoma Patients Receiving Neoadjuvant Treatment.
Demir D; Parvizi M; Pehlivanoglu B; Ergin E; Ayhan S; Doganavsargil B
Cureus; 2024 Mar; 16(3):e56763. PubMed ID: 38650801
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of ARID1A and ANXA1 in HER-2 Positive Breast Cancer.
Silva-Oliveira R; Pereira FF; Petronilho S; Martins AT; Lameirinhas A; Constâncio V; Caldas-Ribeiro I; Salta S; Lopes P; Antunes L; Castro F; de Sousa SP; Henrique R; Jerónimo C
J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33276477
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of ANXA1 in benign human gastrointestinal tissues and cancers.
Gao Y; Chen Y; Xu D; Wang J; Yu G
BMC Cancer; 2014 Jul; 14():520. PubMed ID: 25038797
[TBL] [Abstract][Full Text] [Related]
14. The prognostic impact of lipid biosynthesis-associated markers, HSD17B2 and HMGCS2, in rectal cancer treated with neoadjuvant concurrent chemoradiotherapy.
Lee YE; He HL; Shiue YL; Lee SW; Lin LC; Wu TF; Chang IW; Lee HH; Li CF
Tumour Biol; 2015 Sep; 36(10):7675-83. PubMed ID: 25929810
[TBL] [Abstract][Full Text] [Related]
15. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients.
Fu CG; Tominaga O; Nagawa H; Nita ME; Masaki T; Ishimaru G; Higuchi Y; Tsuruo T; Muto T
Dis Colon Rectum; 1998 Jan; 41(1):68-74. PubMed ID: 9510313
[TBL] [Abstract][Full Text] [Related]
16. ceRNA Networks: The Backbone Role in Neoadjuvant Chemoradiotherapy Resistance/Sensitivity of Locally Advanced Rectal Cancer.
He L; Chang H; Qi Y; Zhang B; Shao Q
Technol Cancer Res Treat; 2021; 20():15330338211062313. PubMed ID: 34908512
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MLPH in Rectal Cancer Patients Correlates with a Poorer Response to Preoperative Chemoradiotherapy and Reduced Patient Survival.
Li WS; Chen CI; Chen HP; Liu KW; Tsai CJ; Yang CC
Diagnostics (Basel); 2021 Nov; 11(11):. PubMed ID: 34829479
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer.
Dora D; Rivard C; Yu H; Pickard SL; Laszlo V; Harko T; Megyesfalvi Z; Dinya E; Gerdan C; Szegvari G; Hirsch FR; Dome B; Lohinai Z
Biology (Basel); 2021 Jun; 10(6):. PubMed ID: 34200100
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of targeting
Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
[TBL] [Abstract][Full Text] [Related]
20. PCSK1 Overexpression in Rectal Cancer Correlates with Poor Response to Preoperative Chemoradiotherapy and Prognosis.
Chou CL; Chen TJ; Lin CY; Lee SW; Wang SC; Chu SS; Yang CC
Onco Targets Ther; 2020; 13():3141-3150. PubMed ID: 32346297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
